O	0	6	Effect	Effect	NN	B-NP
O	7	9	of	of	IN	B-PP
O	10	11	1	1	CD	B-NP
O	11	12	-	-	HYPH	I-NP
O	12	28	alkylpyrrolidine	alkylpyrrolidine	NN	I-NP
O	29	30	N	N	NN	I-NP
O	30	31	-	-	HYPH	O
O	31	37	oxides	oxide	NNS	B-NP
O	38	40	on	on	IN	B-PP
O	41	47	energy	energy	NN	B-NP
O	48	58	metabolism	metabolism	NN	I-NP
O	59	61	of	of	IN	B-PP
B-Cell	62	68	cancer	cancer	NN	B-NP
I-Cell	69	74	cells	cell	NNS	I-NP
O	74	75	.	.	.	O

O	76	79	The	The	DT	B-NP
O	80	84	main	main	JJ	I-NP
O	85	92	purpose	purpose	NN	I-NP
O	93	95	of	of	IN	B-PP
O	96	99	the	the	DT	B-NP
O	100	107	present	present	JJ	I-NP
O	108	121	investigation	investigation	NN	I-NP
O	122	125	was	be	VBD	B-VP
O	126	128	to	to	TO	B-VP
O	129	134	study	study	VB	I-VP
O	135	138	the	the	DT	B-NP
O	139	145	effect	effect	NN	I-NP
O	146	148	of	of	IN	B-PP
O	149	150	a	a	DT	B-NP
O	151	161	homologous	homologous	JJ	I-NP
O	162	168	series	series	NN	I-NP
O	169	171	of	of	IN	B-PP
O	172	173	1	1	CD	B-NP
O	173	174	-	-	HYPH	I-NP
O	174	190	alkylpyrrolidine	alkylpyrrolidine	NN	I-NP
O	191	192	N	N	NN	I-NP
O	192	193	-	-	HYPH	O
O	193	199	oxides	oxide	NNS	B-NP
O	200	202	on	on	IN	B-PP
O	203	206	ATP	ATP	NN	B-NP
O	206	207	-	-	HYPH	O
O	207	216	producing	produce	VBG	B-VP
O	217	226	processes	process	NNS	B-NP
O	227	229	in	in	IN	B-PP
B-Cell	230	237	Ehrlich	Ehrlich	NNP	B-NP
I-Cell	238	245	ascites	ascite	NNS	I-NP
O	246	249	and	and	CC	O
B-Cell	250	255	L1210	L1210	NN	B-NP
I-Cell	256	262	murine	murine	JJ	I-NP
I-Cell	263	271	leukemia	leukemia	NN	I-NP
I-Cell	272	277	cells	cell	NNS	I-NP
O	277	278	.	.	.	O

O	279	282	The	The	DT	B-NP
O	283	289	effect	effect	NN	I-NP
O	290	292	on	on	IN	B-PP
O	293	300	aerobic	aerobic	JJ	B-NP
O	301	308	glucose	glucose	NN	I-NP
O	309	320	consumption	consumption	NN	I-NP
O	320	321	,	,	,	O
O	322	328	lactic	lactic	JJ	B-NP
O	329	333	acid	acid	NN	I-NP
O	334	343	formation	formation	NN	I-NP
O	343	344	,	,	,	O
O	345	352	content	content	NN	B-NP
O	353	355	of	of	IN	B-PP
O	356	361	total	total	NN	B-NP
O	362	363	(	(	(	I-NP
O	363	364	T	T	NN	I-NP
O	364	365	-	-	HYPH	I-NP
O	365	367	SH	SH	NN	I-NP
O	367	368	)	)	)	O
O	369	372	and	and	CC	O
O	373	376	non	non	AFX	B-NP
O	376	377	-	-	HYPH	I-NP
O	377	384	protein	protein	NN	I-NP
O	385	390	thiol	thiol	NN	I-NP
O	391	397	groups	group	NNS	I-NP
O	398	399	(	(	(	O
O	399	401	NP	NP	NN	B-NP
O	401	402	-	-	HYPH	O
O	402	404	SH	SH	NN	B-NP
O	404	405	)	)	)	O
O	405	406	,	,	,	O
O	407	417	endogenous	endogenous	JJ	B-NP
O	418	429	respiration	respiration	NN	I-NP
O	430	433	and	and	CC	O
O	434	437	the	the	DT	B-NP
O	438	443	level	level	NN	I-NP
O	444	446	of	of	IN	B-PP
O	447	450	ATP	ATP	NN	B-NP
O	451	453	in	in	IN	B-PP
B-Cell	454	459	tumor	tumor	NN	B-NP
I-Cell	460	465	cells	cell	NNS	I-NP
O	466	475	incubated	incubate	VBN	B-VP
O	476	478	in	in	FW	B-ADVP
O	479	484	vitro	vitro	FW	I-ADVP
O	485	488	was	be	VBD	B-VP
O	489	501	investigated	investigate	VBN	I-VP
O	501	502	.	.	.	O

O	503	504	1	1	CD	B-NP
O	504	505	-	-	HYPH	I-NP
O	505	526	Tetradecylpyrrolidine	Tetradecylpyrrolidine	NN	I-NP
O	527	528	N	N	NN	I-NP
O	528	529	-	-	HYPH	O
O	529	534	oxide	oxide	NN	B-NP
O	535	536	(	(	(	O
O	536	540	TPNO	TPNO	NN	B-NP
O	540	541	)	)	)	O
O	541	542	,	,	,	O
O	543	546	one	one	CD	B-NP
O	547	549	of	of	IN	B-PP
O	550	553	the	the	DT	B-NP
O	554	558	most	most	RBS	I-NP
O	559	565	active	active	JJ	I-NP
O	566	575	compounds	compound	NNS	I-NP
O	575	576	,	,	,	O
O	577	588	immediately	immediately	RB	B-ADVP
O	589	594	after	after	IN	B-SBAR
O	595	603	addition	addition	NN	B-NP
O	604	606	to	to	TO	B-PP
O	607	610	the	the	DT	B-NP
O	611	621	suspension	suspension	NN	I-NP
O	622	624	of	of	IN	B-PP
B-Cell	625	632	Ehrlich	Ehrlich	NN	B-NP
I-Cell	633	638	cells	cell	NNS	I-NP
O	639	641	in	in	IN	B-PP
O	642	644	an	an	DT	B-NP
O	645	648	ice	ice	NN	I-NP
O	649	653	bath	bath	NN	I-NP
O	653	654	,	,	,	O
O	655	664	decreased	decrease	VBD	B-VP
O	665	668	the	the	DT	B-NP
O	669	674	level	level	NN	I-NP
O	675	677	of	of	IN	B-PP
O	678	681	ATP	ATP	NN	B-NP
O	682	684	to	to	TO	B-PP
O	685	688	the	the	DT	B-NP
O	689	693	same	same	JJ	I-NP
O	694	700	extent	extent	NN	I-NP
O	701	705	over	over	IN	B-PP
O	706	709	the	the	DT	B-NP
O	710	715	whole	whole	JJ	I-NP
O	716	729	concentration	concentration	NN	I-NP
O	730	735	range	range	NN	I-NP
O	735	736	.	.	.	O

O	737	742	After	After	IN	B-PP
O	743	744	2	2	CD	B-NP
O	745	746	h	h	NN	I-NP
O	747	757	incubation	incubation	NN	I-NP
O	758	760	at	at	IN	B-PP
O	761	763	37	37	CD	B-NP
O	764	771	degrees	degree	NNS	I-NP
O	772	773	C	C	JJ	B-ADJP
O	774	777	the	the	DT	B-NP
O	778	782	drop	drop	NN	I-NP
O	783	785	in	in	IN	B-PP
O	786	789	the	the	DT	B-NP
O	790	793	ATP	ATP	NN	I-NP
O	794	799	level	level	NN	I-NP
O	800	803	was	be	VBD	B-VP
O	804	809	lower	low	JJR	B-ADJP
O	809	810	.	.	.	O

O	811	814	The	The	DT	B-NP
O	815	823	decrease	decrease	NN	I-NP
O	824	826	in	in	IN	B-PP
O	827	830	ATP	ATP	NN	B-NP
O	831	836	level	level	NN	I-NP
O	837	842	might	might	MD	B-VP
O	843	845	be	be	VB	I-VP
O	846	855	explained	explain	VBN	I-VP
O	856	863	through	through	IN	B-PP
O	864	867	the	the	DT	B-NP
O	868	879	interaction	interaction	NN	I-NP
O	880	882	of	of	IN	B-PP
O	883	886	the	the	DT	B-NP
O	887	892	amine	amine	NN	I-NP
O	893	898	oxide	oxide	NN	I-NP
O	899	903	with	with	IN	B-PP
O	904	907	the	the	DT	B-NP
B-Cellular_component	908	912	cell	cell	NN	I-NP
I-Cellular_component	913	921	membrane	membrane	NN	I-NP
O	922	931	integrity	integrity	NN	I-NP
O	931	932	.	.	.	O

